Scientists at St. Jude Children's Research Hospital and Northwestern University identified a previously unknown treatment ...
In a world-first trial, scientists used a one-off CRISPR gene edit to switch off a liver “fat brake” gene, slashing stubborn ...
News-Medical.Net on MSN
One-time CRISPR therapy safely lowers cholesterol and triglycerides in early trial
In a 15-patient, Phase 1 one, first-in-human trial, a one-time, CRISPR-Cas9 gene-editing therapy safely reduced LDL ...
In a new Northwestern Medicine study, scientists have developed a more precise genetic risk score to determine whether a ...
Texas A&M scientists have unlocked new potential for astatine-211, a rare and short-lived element, as a highly precise cancer-fighting isotope. Its alpha emissions destroy tumor cells while sparing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback